Previous Article | Next Article 
Journal of Clinical Microbiology, September 1998, p. 2732-2734, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phenotypic and Genotypic Characterization of
Virulent Yersinia enterocolitica Strains Unable To
Ferment Sucrose
Annie
Guiyoule,1
Françoise
Guinet,1
Liliane
Martin,1
Catherine
Benoit,1
Nicole
Desplaces,2 and
Elisabeth
Carniel1,*
National Reference Laboratory and WHO
Collaborating Center for Yersinia, Institut Pasteur, 75724 Paris
Cedex 15,1 and
Hôpital de la Croix
Saint-Simon, 75960 Paris Cedex 20,2 France
Received 24 March 1998/Returned for modification 24 April
1998/Accepted 1 June 1998
 |
ABSTRACT |
Several atypical sucrose-negative Yersinia strains,
isolated from clinical samples and sometimes associated with symptoms, proved to have full virulence potential in in vitro and in vivo testings. DNA-relatedness studies revealed that they were authentic Yersinia enterocolitica strains. Therefore, atypical
sucrose-negative Yersinia isolates should be analyzed for
their virulence potential.
 |
TEXT |
Some bioserotypes of Yersinia
enterocolitica correlate with potential pathogenicity in humans
(6, 10). Most commonly isolated in
gastrointestinal infections are bioserotypes 4/O:3, 2/O:9, and
2-3/O:5-5,27 (5, 9). The Y. enterocolitica-related species can share antigenic
reactivities with Y. enterocolitica sensu stricto,
but they are avirulent.
Among the biochemical traits that differentially characterize these
Y. enterocolitica-related and -sensu stricto species, lack of sucrose fermentation has been a distinct feature of
Y. kristensenii (2, 3, 17).
Consequently, sucrose-negative Y. enterocolitica-like organisms isolated from clinical
specimens have been regarded as avirulent, and in routine
practice, they are not characterized further. The present report,
however, describes a series of sucrose-negative,
Voges-Proskauer (VP)-positive Y. enterocolitica-like isolates that proved, upon thorough
characterization, to be fully pathogenic strains of Y. enterocolitica.
Detection of atypical Y. enterocolitica-like
clinical isolates.
A Yersinia strain, IP22109, was
recovered in large numbers on CIN agar base (Difco) from the feces of a
24-year-old man hospitalized at the La Croix St. Simon Hospital, Paris,
France, for high fever (39°C), diarrhea, and pain in the right iliac
fossa. This case was one of several cases of acute gastroenteritis
traced to a common meal, suggesting a food-borne outbreak although this
small outbreak was not further investigated. No other potentially
pathogenic microorganism was isolated from the stool samples. IP22109
was of serotype O:5. The patient's serum was able to agglutinate the Y. enterocolitica O:5 reference strain as well as its
homologous strain, indicating that the latter had triggered an immune
response. IP22109 displayed an atypical biochemical profile, since
sucrose negativity, typical of Y. kristensenii
(3), was associated with a positive VP test which is
negative in this species but is positive in Y. enterocolitica (3). The association between sucrose
negativity and VP positivity has been occasionally observed in biotype
5 of Y. enterocolitica. This very uncommon biotype, however, is associated with serotype O:2,3, as opposed to serotype O:5
of IP22109.
A search of the 22,000-strain collection of the Yersinia
Reference Laboratory and WHO Collaborating Center, Pasteur Institute, for sucrose-negative, VP-positive Yersinia isolates of
serotype O:5 yielded four such strains. They all had been isolated from human stools, and the presence of concomitant digestive symptoms had been recorded for two of them (Table
1). They were, therefore, further
characterized along with IP22109.
In vitro and in vivo virulence tests.
Pathogenic
Yersinia strains carry the 70-kb pYV plasmid, which
encodes essential virulence determinants. Four in vitro tests were used
to address the presence of pYV in the five atypical isolates. Indirect
assessment of the plasmid presence was obtained by (i) plating the
strains on magnesium-oxalate agar (MOX test) in search for the growth
inhibition triggered by the pYV plasmid under low-calcium conditions at
37°C (11, 16) and (ii) checking bacterial
autoagglutination mediated by the pYV-encoded YadA adhesin upon
incubation at 37°C in RPMI medium (1, 13). Direct
detection of pYV was then performed by colony hybridization with a
yadA-specific probe and by plasmid extraction. The MOX and
autoagglutination tests were done as described previously (11,
13). The yadA-specific probe used for colony
hybridization was obtained by nested PCR of plasmid DNA from
Y. enterocolitica IP864 with the pairs of primers
5'-CTGCAAATAAGCTATACCGAT-3' and
5'-ATGCCTGACTAGAACGATAT-3' for the first reaction, and
5'-GTGACTGTAAGTAGTTCGACT-3' and
5'-CCGACACCTGCAGTAAAGTT-3' for the second reaction. PCRs and
digoxigenin labeling during the second PCR were performed as published
previously (8), except that the first PCR was done with 10 ng of template DNA and with primers at a final concentration of 1 µM each, and in the second PCR, each unlabeled nucleotide was at a
final concentration of 40 µM. The first PCR mixture was denatured at
94°C for 2 min and then amplified for 24 cycles at 94°C for 1 min,
54°C for 1 min 30 s, and 72°C for 2 min. The last cycle
was followed by a 10-min incubation at 72°C. Amplification products
were reamplified with the second primer set and the same PCR parameters
as above, except for the priming step, which was carried out at 58°C.
Colony transfer and hybridization were performed as published
previously (8), and immunological detection of the probe was
done according to the manufacturer's instructions (Boehringer).
Plasmid extraction was performed according to the method of
Birnboim and Doly (4).
As shown in Table 1 and Fig. 1, the
results of the four pYV detection assays were in agreement and showed
that all of the atypical strains except IP10664 harbored the 70-kb
virulence plasmid. In the IP7230 Y. kristensenii
control strain, these tests consistently failed to detect the plasmid.

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 1.
Plasmid fingerprinting of the atypical isolates.
EcoRI-restricted plasmids were resolved on a 0.8% agarose
gel, ethidium bromide stained, and visualized under UV illumination.
Comparison of the plasmid restriction patterns shows that most of the
atypical strains harbor the pYV plasmid. Within the O:5 strains
(lanes 1 to 6), the only detectable difference in the restriction
profiles is an apparent size increase in a low-molecular-weight
fragment of strains IP22914 and IP22109 (arrow). Lanes: 1, IP17381; 2, IP19817; 3, IP10664; 4, IP22109; 5, IP22914; 6, IP22228
(control Y. enterocolitica O:5 strain known to harbor
pYV). The atypical strain of serotype O:9 (IP25686, lane 8) had a
plasmid profile identical to that of the Y. enterocolitica O:9 control strain, IP23073 (lane 7). and M,
/HindIII and 1-kb-ladder molecular weight markers,
respectively (GibcoBRL). Sizes are in kilobases.
|
|
The atypical isolates were also assayed for pyrazinamidase activity as
a plasmid-independent virulence test (12). Absence of
detectable pyrazinamidase activity, which correlates with
potential pathogenicity in Y. enterocolitica and
related organisms (12), was found to be a feature of all
atypical isolates (Table 1). This result indicated that the atypical
Yersinia strains were all potentially pathogenic, although
one of them had lost its pYV plasmid.
The pathogenicity of the atypical strains was confirmed in vivo by
using the iron-overloaded mouse model (15). All 50% lethal doses (LD50s) were determined as described previously
(7) for groups of five intravenously infected OF1 female
mice (Iffa Credo, France). The plasmid-harboring atypical strains
proved to be as virulent as the pathogenic Y. enterocolitica IP22228 control, with LD50s
ranging between 2 × 104 and 2 × 105
CFU (Table 1). The LD50 of the avirulent Y. kristensenii reference strain, IP7230, was markedly higher,
with a more than 5,000-fold increase relative to that of the
pathogenic Y. enterocolitica strains.
The virulence potential of the atypical strains demonstrated by
the in vitro and in vivo testings was in keeping with the symptomatology associated with these strains (Table 1). It also strongly suggested that the atypical isolates belonged to
Y. enterocolitica rather than to Y. kristensenii, since the pYV virulence plasmid is exclusively found
in the three pathogenic species of Yersinia, i.e.,
Y. pestis, Y. pseudotuberculosis,
and Y. enterocolitica. Definitive species
assignment was achieved by DNA-relatedness measurements.
Species assignment.
DNA-DNA hybridizations were
performed with the atypical strains IP10664 and IP19817 and the
control strains Y. enterocolitica IP22228 and
Y. kristensenii IP105, according to the protocol
published by Popoff and Coynault (14). DNA labeling of
the control strains, assessment of the degree of hybridization, and
normalization to the homologous reaction were as described previously
(14). As shown in Table 2, the
atypical organisms shared a high degree of relatedness with the
Y. enterocolitica control strain, IP22228 (>93%), and
a low degree of relatedness (
49%) with the Y. kristensenii reference strain, IP105. Therefore, the DNA
hybridization studies conclusively ascribed the atypical
strains to the Y. enterocolitica species.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
DNA relatedness of two atypical Yersinia
strains with a control Y. enterocolitica O:5 strain
and the Y. kristensenii reference strain
|
|
Detection of an atypical Y. enterocolitica strain
of bioserotype 2/O:9.
One additional sucrose-negative,
VP-positive Yersinia strain, IP25686, was identified
in the Yersinia Reference Laboratory collection upon
screening of the entire database. This strain was of bioserotype
2/O:9. IP25686 had the virulence characteristics of
enteropathogenic Y. enterocolitica, because it belonged
to a pathogenic bioserotype, possessed the pYV plasmid (Fig. 1), and
lacked detectable pyrazinamidase activity (Table 1).
All of the sucrose-negative Y. enterocolitica strains,
whatever their serotype, were of biotype 2 (Table 1). Since this
biotype is much less common in France than biotype 4, its
constant association with the loss of sucrose fermentation in
this series might reflect a genetic or a biochemical linkage between
the two phenotypic traits.
The results presented above demonstrate the existence of fully
pathogenic sucrose-negative Y. enterocolitica
strains within two of the most common pathogenic bioserotypes.
The pYV plasmid-containing atypical Y. enterocolitica
strains were pathogenic for mice to the same degree as a
sucrose-positive control, indicating that full virulence of
Y. enterocolitica in mice is not dependent on sucrose
fermentation. Furthermore, the cluster of acute clinical cases
associated with one atypical strain suggests that pathogenic potential
in humans is retained upon loss of sucrose fermentation. Although loss
of sucrose fermentation does not alter the virulence of Y. enterocolitica, the fact that this biochemical property is almost
perfectly retained in the species suggests that it is beneficial for
the bacterium, possibly when it is outside of its host.
An important clinical implication of this work is that sucrose-negative
yersiniae can be virulent and can therefore be held responsible
for acute and delayed pathologic manifestations typical of
enteropathogenic yersiniae, e.g., enteritis, erythema nodosum, and arthropathies. Any sucrose-negative Y. enterocolitica-like organism with associated symptomatology should
be characterized further, especially if the VP reaction is positive.
Determination of the atypical isolate biotype, serotype, and, in
certain cases, phagetype, along with the pyrazinamidase test may be
simple means to orient the bacteriological diagnosis. If necessary,
these tests should be completed by in vitro and in vivo virulence
evaluations.
 |
ACKNOWLEDGMENTS |
We thank David Yelton for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire des
Yersinia, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.
Phone: 33-1-4568-8326. Fax: 33-1-4061-3001. E-mail:
carniel2{at}pasteur.fr.
 |
REFERENCES |
| 1.
|
Balligand, G.,
Y. Laroche, and G. Cornelis.
1985.
Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination.
Infect. Immun.
48:782-786[Abstract/Free Full Text].
|
| 2.
|
Bercovier, H.,
D. J. Brenner,
J. Ursing,
A. G. Steigerwalt,
G. R. Fanning,
J.-M. Alonso,
G. P. Carter, and H. H. Mollaret.
1980.
Characterization of Yersinia enterocolitica sensu stricto.
Curr. Microbiol.
4:201-206.
|
| 3.
|
Bercovier, H.,
J. Ursing,
D. J. Brenner,
A. G. Steigerwalt,
G. R. Fanning,
G. P. Carter, and H. H. Mollaret.
1980.
Yersinia kristensenii: a new species of Enterobacteriaceae composed of sucrose-negative strains (formerly called atypical Yersinia enterocolitica or Yersinia enterocolitica-like).
Curr. Microbiol.
4:219-224.
|
| 4.
|
Birnboim, H. C., and J. Doly.
1979.
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res.
7:1513-1523[Abstract/Free Full Text].
|
| 5.
|
Bottone, E. J.
1981.
Yersinia enterocolitica.
CRC Press, Inc., Boca Raton, Fla.
|
| 6.
|
Bottone, E. J.
1997.
Yersinia enterocolitica: the charisma continues.
Clin. Microbiol. Rev.
10:257-276[Abstract].
|
| 7.
|
Carniel, E.,
A. Guiyoule,
I. Guilvout, and O. Mercereau-Puijalon.
1992.
Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia.
Mol. Microbiol.
6:379-388[Medline].
|
| 8.
|
Chenal, V., and R. Griffais.
1994.
Chemiluminescent and colorimetric detection of a fluorescein-labelled probe and a digoxigenin-labelled probe after a single hybridization step.
Mol. Cell. Probes
8:401-407[Medline].
|
| 9.
|
Cornelis, G.,
Y. Laroche,
G. Balligand,
M.-P. Sory, and G. Wauters.
1987.
Yersinia enterocolitica, a primary model for bacterial invasiveness.
Rev. Infect. Dis.
9:64-87[Medline].
|
| 10.
|
Farmer, J. J., III,
G. P. Carter,
V. L. Miller,
S. Falkow, and I. K. Wachsmuth.
1992.
Pyrazinamidase, CR-MOX agar, salicin fermentation-esculin hydrolysis, and D-xylose fermentation for identifying pathogenic serotypes of Yersinia enterocolitica.
J. Clin. Microbiol.
30:2589-2594[Abstract/Free Full Text].
|
| 11.
|
Higuchi, K., and J. L. Smith.
1961.
Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence.
J. Bacteriol.
81:605-608[Free Full Text].
|
| 12.
|
Kandolo, K., and G. Wauters.
1985.
Pyrazinamidase activity in Yersinia enterocolitica and related organisms.
J. Clin. Microbiol.
21:980-982[Abstract/Free Full Text].
|
| 13.
|
Laird, W. J., and D. C. Cavanaugh.
1980.
Correlation of autoagglutination and virulence of yersiniae.
J. Clin. Microbiol.
11:430-432[Abstract/Free Full Text].
|
| 14.
|
Popoff, M., and C. Coynault.
1980.
Use of DEA-cellulose filters in the S1 nuclease method for bacterial deoxyribonucleic acid hybridization.
Ann. Inst. Pasteur
131:151-155.
|
| 15.
|
Robins-Browne, R. M., and J. Kaya Prpic.
1985.
Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.
Infect. Immun.
47:774-779[Abstract/Free Full Text].
|
| 16.
|
Straley, S. C., and R. D. Perry.
1995.
Environmental modulation of gene expression and pathogenesis in Yersinia.
Trends Microbiol.
3(8):310-317[Medline].
|
| 17.
|
Wauters, G.,
M. Janssens,
A. G. Steigerwalt, and D. J. Brenner.
1988.
Yersinia mollaretii sp. nov. and Yersinia bercovieri sp. nov., formerly called Yersinia enterocolitica biogroups 3A and 3B.
Int. J. Syst. Bacteriol.
38:424-429[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, September 1998, p. 2732-2734, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
STOCK, I., HENRICHFREISE, B., WIEDEMANN, B.
(2002). Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri'. J Med Microbiol
51: 56-69
[Abstract]
[Full Text]